Movement Alert｜Twist Bioscience Corp Intraday Rise 8.39%, earnings expectations and Eli Lilly collaboration remain in focus

Market Focus11-11 22:43

On November 11, Twist Bioscience Corp rose 8.39% in Regular Trading, trading at $142.79 per share, with turnover of $31.8688 million.

The move coincided with continued market focus on the company’s upcoming quarterly results, consensus expectations for about $123 million in revenue with narrowing losses, and progress in its antibody characterization data services collaboration with Eli Lilly’s TuneLab platform.

Available market commentary ahead of the November 12 earnings release points to quarterly revenue of about $123 million, up 25.96% year over year, while adjusted EPS is expected at a loss of $0.37 to $0.44 per share. Separate reports also noted broadly positive institutional sentiment, including an average target price near $150.33, alongside discussion of potential AI drug discovery-related order momentum. In September, the company said it would provide antibody characterization data services to Lilly TuneLab, an AI and machine learning drug discovery platform.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment